Name: UMIN ID:
Unique ID issued by UMIN | UMIN000018383 |
---|---|
Receipt number | R000021216 |
Scientific Title | A Phase Ib study of Trastuzumab emtansine plus S-1 or Capecitabine in patients with previously trastuzumab treated metastatic breast cancer |
Date of disclosure of the study information | 2015/07/23 |
Last modified on | 2018/01/23 14:04:28 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/07/22 16:01:43 | ||
2 | Update | 2015/07/23 10:01:53 | Acronym Acronym |
|
3 | Update | 2015/07/29 09:10:20 | Basic design Control No. of arms Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
4 | Update | 2015/07/31 18:18:07 | Basic design Control No. of arms Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
5 | Update | 2016/08/09 10:15:41 | Division name Division name Name of primary person or sponsor Organization |
|
6 | Update | 2018/01/23 14:04:28 | Recruitment status Date of protocol fixation Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |